6WPQ

GNYNVF from hnRNPA2-low complexity domain segment, residues 286-291, D290V variant

External Resource: Annotation

Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF11627	Heterogeneous nuclear ribonucleoprotein A1, LC domain (HnRNPA1_LC)	Heterogeneous nuclear ribonucleoprotein A1, LC domain	This entry includes hnRNPA1, a nuclear factor that binds to Pol II transcripts. The family of hnRNP proteins are involved in numerous RNA-related activities [1]. hnRNPA1 is involved in the packaging of pre-mRNA into hnRNP particles, transport of poly ...	This entry includes hnRNPA1, a nuclear factor that binds to Pol II transcripts. The family of hnRNP proteins are involved in numerous RNA-related activities [1]. hnRNPA1 is involved in the packaging of pre-mRNA into hnRNP particles, transport of poly(A) mRNA from the nucleus to the cytoplasm and modulation of splice site selection [2]. hnRNPA1 plays a role in the splicing of pyruvate kinase PKM by binding repressively to sequences flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform [3]. This protein binds to the IRES and inhibits the translation of the apoptosis protease activating factor APAF1. During Enterovirus 71 (EV71) infection, APAF1 expression is essential for virus-induced apoptosis and viral particle release [4]. HnRNPA1 has two RNA recognition motifs (RRM1 and RRM2) followed by an unstructured low complexity (LC) C-terminal domain, represented in this entry [5]. This domain can mediate protein-protein and protein-RNA interactions and it is involved in amyloid aggregation, leading to neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and multisystem proteinopathy (MSP) [5].	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	Heterogeneous nuclear ribonucleoprotein A2	protein-RNA adaptor activity protein-macromolecule adaptor activity N6-methyladenosine-containing RNA reader activity molecular adaptor activity molecular condensate scaffold activity mRNA 3'-UTR binding RNA binding binding organic cyclic compound binding nucleic acid binding mRNA binding regulatory RNA binding miRNA binding sequence-specific DNA binding protein-RNA adaptor activity protein-macromolecule adaptor activity N6-methyladenosine-containing RNA reader activity molecular adaptor activity molecular condensate scaffold activity mRNA 3'-UTR binding RNA binding binding organic cyclic compound binding nucleic acid binding mRNA binding regulatory RNA binding miRNA binding sequence-specific DNA binding DNA binding G-rich strand telomeric DNA binding sequence-specific single stranded DNA binding single-stranded telomeric DNA binding single-stranded DNA binding telomeric DNA binding pre-mRNA binding pre-mRNA intronic binding identical protein binding protein binding	regulation of cellular process negative regulation of biological process regulation of mRNA splicing, via spliceosome mRNA processing negative regulation of cellular metabolic process regulation of primary metabolic process nucleobase-containing compound metabolic process regulation of RNA metabolic process negative regulation of mRNA splicing, via spliceosome organic substance biosynthetic process negative regulation of nucleobase-containing compound metabolic process regulation of nucleobase-containing compound metabolic process RNA processing negative regulation of mRNA processing regulation of cellular process negative regulation of biological process regulation of mRNA splicing, via spliceosome mRNA processing negative regulation of cellular metabolic process regulation of primary metabolic process nucleobase-containing compound metabolic process regulation of RNA metabolic process negative regulation of mRNA splicing, via spliceosome organic substance biosynthetic process negative regulation of nucleobase-containing compound metabolic process regulation of nucleobase-containing compound metabolic process RNA processing negative regulation of mRNA processing regulation of biological process cellular metabolic process negative regulation of metabolic process primary metabolic process regulation of cellular metabolic process negative regulation of cellular biosynthetic process organic cyclic compound metabolic process regulation of gene expression negative regulation of gene expression biosynthetic process negative regulation of macromolecule biosynthetic process metabolic process regulation of macromolecule biosynthetic process macromolecule metabolic process regulation of metabolic process negative regulation of RNA metabolic process cellular biosynthetic process RNA metabolic process negative regulation of mRNA metabolic process organic substance metabolic process negative regulation of cellular process negative regulation of macromolecule metabolic process regulation of biosynthetic process regulation of mRNA processing RNA splicing biological regulation regulation of macromolecule metabolic process gene expression regulation of RNA splicing mRNA metabolic process macromolecule biosynthetic process nucleic acid metabolic process regulation of cellular biosynthetic process negative regulation of RNA splicing RNA splicing, via transesterification reactions negative regulation of biosynthetic process mRNA splicing, via spliceosome cellular process RNA splicing, via transesterification reactions with bulged adenosine as nucleophile regulation of mRNA metabolic process positive regulation of organelle organization regulation of telomere maintenance regulation of cellular component organization positive regulation of cellular component organization positive regulation of biological process telomere organization telomere maintenance via telomere lengthening cellular component organization positive regulation of metabolic process positive regulation of telomere maintenance via telomere lengthening positive regulation of macromolecule metabolic process cellular component organization or biogenesis positive regulation of cellular process positive regulation of telomere maintenance positive regulation of nucleobase-containing compound metabolic process chromosome organization DNA metabolic process regulation of chromosome organization regulation of telomere maintenance via telomere lengthening regulation of organelle organization positive regulation of chromosome organization telomere maintenance organelle organization positive regulation of DNA metabolic process regulation of DNA metabolic process RNA transport nitrogen compound transport transport organic substance transport nucleic acid transport mRNA transport establishment of localization localization establishment of RNA localization macromolecule localization RNA localization nucleobase-containing compound transport cellular localization nucleocytoplasmic transport nuclear transport mRNA export from nucleus establishment of localization in cell nuclear export intracellular transport RNA export from nucleus G-quadruplex DNA unwinding DNA geometric change DNA conformation change miRNA transport regulatory ncRNA processing regulatory ncRNA-mediated gene silencing primary miRNA processing miRNA processing negative regulation of RNA biosynthetic process DNA-templated transcription transcription by RNA polymerase II regulation of transcription by RNA polymerase II negative regulation of DNA-templated transcription negative regulation of transcription by RNA polymerase II organic cyclic compound biosynthetic process regulation of DNA-templated transcription RNA biosynthetic process nucleic acid biosynthetic process regulation of RNA biosynthetic process nucleobase-containing compound biosynthetic process regulation of telomerase activity regulation of catalytic activity regulation of transferase activity regulation of DNA biosynthetic process positive regulation of molecular function positive regulation of transferase activity positive regulation of telomerase RNA reverse transcriptase activity positive regulation of catalytic activity regulation of telomerase RNA reverse transcriptase activity regulation of molecular function DNA biosynthetic process	membrane-bounded organelle intracellular anatomical structure nucleus membrane-enclosed lumen intracellular membrane-bounded organelle cellular anatomical entity intracellular organelle lumen intracellular organelle organelle lumen organelle nuclear periphery nuclear lumen nuclear matrix membrane membrane-bounded organelle intracellular anatomical structure nucleus membrane-enclosed lumen intracellular membrane-bounded organelle cellular anatomical entity intracellular organelle lumen intracellular organelle organelle lumen organelle nuclear periphery nuclear lumen nuclear matrix membrane catalytic step 2 spliceosome protein-containing complex catalytic complex nuclear protein-containing complex spliceosomal complex ribonucleoprotein complex extracellular exosome extracellular vesicle extracellular organelle extracellular region extracellular space vesicle extracellular membrane-bounded organelle cytoplasm nucleoplasm Cajal body nuclear body intracellular non-membrane-bounded organelle chromosome chromosome, telomeric region chromosomal region non-membrane-bounded organelle

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR000504	RNA recognition motif domain	Domain
A	IPR021662	Heterogeneous nuclear ribonucleoprotein A1/A2, C-terminal	Domain
A	IPR012677	Nucleotide-binding alpha-beta plait domain superfamily	Homologous Superfamily
A	IPR034486	hnRNP A2/B1, RNA recognition motif 1	Domain
A	IPR035979	RNA-binding domain superfamily	Homologous Superfamily

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: P22626	adult T-cell leukemia/lymphoma inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2 inclusion body myopathy with Paget disease of bone and frontotemporal dementia Pick disease primitive neuroectodermal tumor acute T cell leukemia atypical teratoid rhabdoid tumor large cell medulloblastoma malignant glioma myopathy pancreatic ductal adenocarcinoma plasma cell myeloma progressive supranuclear palsy glioblastoma inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1 adult T-cell leukemia/lymphoma inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2 inclusion body myopathy with Paget disease of bone and frontotemporal dementia Pick disease primitive neuroectodermal tumor acute T cell leukemia atypical teratoid rhabdoid tumor large cell medulloblastoma malignant glioma myopathy pancreatic ductal adenocarcinoma plasma cell myeloma progressive supranuclear palsy glioblastoma inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1 lymphoplasmacytic lymphoma malignant pancreatic neoplasm oligodendroglioma pancreatic intraductal papillary-mucinous neoplasm polycystic ovary syndrome astrocytic tumor juvenile dermatomyositis malignant ependymoma medulloblastoma ovarian cancer

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.